D. Phippard et al., CHANGES IN THE SUBCELLULAR-LOCALIZATION OF THE BRN4 GENE-PRODUCT PRECEDE MESENCHYMAL REMODELING OF THE OTIC CAPSULE, Hearing research, 120(1-2), 1998, pp. 77-85
To better understand the genetic mechanisms that regulate the formatio
n of the temporal bone, we have characterized the developmental expres
sion pattern of the mouse gene, Brn4/Pou3f4, which plays a central rol
e in bony labyrinth formation. Expression of this gene is initially de
tected in the ventral aspect of the otic capsule at 10.5 days post coi
tus (dpc), and correlates with the onset of mesenchymal condensation i
n the oric capsule. As the otic capsule condenses further and surround
s the entire otic vesicle, the Brn4 gene product is detected throughou
t the inner ear in the mesenchyme of both the cochlear and vestibular
aspects. Early in otic embryogenesis, the Brn4 gene product is localiz
ed to the nucleus of the vast majority of cells in which it is express
ed. The Brn4 gene product remains nuclear in those regions of the otic
capsule that eventually give rise to the mature bony labyrinth. Howev
er, the subcellular localization of the Brn4 gene product shifts from
strictly nuclear to perinuclear in those regions of the otic capsule t
hat will cavitate to form acellular regions in the temporal bone, such
as the scala tympani, scala vestibuli, and the internal auditory meat
us. These data provide a detailed analysis of the expression pattern o
f the Brn4 gene, and provide insight into the role of the Brn4 gene pr
oduct and its regulation during otic capsule formation. (C) 1998 Publi
shed by Elsevier Science B.V. All rights reserved.